Global Long Acting Insulins Market Growth (Status and Outlook) 2025-2031

September 2025 | 80 pages | ID: G8690AB89FFEN
LP Information

Abstracts

According to this study, the global Long Acting Insulins market size will reach US$ million by 2031.

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.

United States market for Long Acting Insulins is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Long Acting Insulins is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Long Acting Insulins is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Long Acting Insulins players cover Novo Nordisk, Sanofi, Wockhardt UK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Long Acting Insulins Industry Forecast” looks at past sales and reviews total world Long Acting Insulins sales in 2024, providing a comprehensive analysis by region and market sector of projected Long Acting Insulins sales for 2025 through 2031. With Long Acting Insulins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long Acting Insulins industry.

This Insight Report provides a comprehensive analysis of the global Long Acting Insulins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long Acting Insulins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long Acting Insulins market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long Acting Insulins and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long Acting Insulins.

This report presents a comprehensive overview, market shares, and growth opportunities of Long Acting Insulins market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Insulin Glargine
• Insulin Determir
• Insulin Degludec
• Long Acting Animal Insulin

Segmentation by Application:

• Home Use
• Medical Institutions
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• Sanofi
• Wockhardt UK

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Long Acting Insulins Market Size (2020-2031)
  2.1.2 Long Acting Insulins Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Long Acting Insulins by Country/Region (2020, 2024 & 2031)
2.2 Long Acting Insulins Segment by Type
  2.2.1 Insulin Glargine
  2.2.2 Insulin Determir
  2.2.3 Insulin Degludec
  2.2.4 Long Acting Animal Insulin
2.3 Long Acting Insulins Market Size by Type
  2.3.1 Long Acting Insulins Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Long Acting Insulins Market Size Market Share by Type (2020-2025)
2.4 Long Acting Insulins Segment by Application
  2.4.1 Home Use
  2.4.2 Medical Institutions
  2.4.3 Others
2.5 Long Acting Insulins Market Size by Application
  2.5.1 Long Acting Insulins Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Long Acting Insulins Market Size Market Share by Application (2020-2025)

3 LONG ACTING INSULINS MARKET SIZE BY PLAYER

3.1 Long Acting Insulins Market Size Market Share by Player
  3.1.1 Global Long Acting Insulins Revenue by Player (2020-2025)
  3.1.2 Global Long Acting Insulins Revenue Market Share by Player (2020-2025)
3.2 Global Long Acting Insulins Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LONG ACTING INSULINS BY REGION

4.1 Long Acting Insulins Market Size by Region (2020-2025)
4.2 Global Long Acting Insulins Annual Revenue by Country/Region (2020-2025)
4.3 Americas Long Acting Insulins Market Size Growth (2020-2025)
4.4 APAC Long Acting Insulins Market Size Growth (2020-2025)
4.5 Europe Long Acting Insulins Market Size Growth (2020-2025)
4.6 Middle East & Africa Long Acting Insulins Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Long Acting Insulins Market Size by Country (2020-2025)
5.2 Americas Long Acting Insulins Market Size by Type (2020-2025)
5.3 Americas Long Acting Insulins Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Long Acting Insulins Market Size by Region (2020-2025)
6.2 APAC Long Acting Insulins Market Size by Type (2020-2025)
6.3 APAC Long Acting Insulins Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Long Acting Insulins Market Size by Country (2020-2025)
7.2 Europe Long Acting Insulins Market Size by Type (2020-2025)
7.3 Europe Long Acting Insulins Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Long Acting Insulins by Region (2020-2025)
8.2 Middle East & Africa Long Acting Insulins Market Size by Type (2020-2025)
8.3 Middle East & Africa Long Acting Insulins Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LONG ACTING INSULINS MARKET FORECAST

10.1 Global Long Acting Insulins Forecast by Region (2026-2031)
  10.1.1 Global Long Acting Insulins Forecast by Region (2026-2031)
  10.1.2 Americas Long Acting Insulins Forecast
  10.1.3 APAC Long Acting Insulins Forecast
  10.1.4 Europe Long Acting Insulins Forecast
  10.1.5 Middle East & Africa Long Acting Insulins Forecast
10.2 Americas Long Acting Insulins Forecast by Country (2026-2031)
  10.2.1 United States Market Long Acting Insulins Forecast
  10.2.2 Canada Market Long Acting Insulins Forecast
  10.2.3 Mexico Market Long Acting Insulins Forecast
  10.2.4 Brazil Market Long Acting Insulins Forecast
10.3 APAC Long Acting Insulins Forecast by Region (2026-2031)
  10.3.1 China Long Acting Insulins Market Forecast
  10.3.2 Japan Market Long Acting Insulins Forecast
  10.3.3 Korea Market Long Acting Insulins Forecast
  10.3.4 Southeast Asia Market Long Acting Insulins Forecast
  10.3.5 India Market Long Acting Insulins Forecast
  10.3.6 Australia Market Long Acting Insulins Forecast
10.4 Europe Long Acting Insulins Forecast by Country (2026-2031)
  10.4.1 Germany Market Long Acting Insulins Forecast
  10.4.2 France Market Long Acting Insulins Forecast
  10.4.3 UK Market Long Acting Insulins Forecast
  10.4.4 Italy Market Long Acting Insulins Forecast
  10.4.5 Russia Market Long Acting Insulins Forecast
10.5 Middle East & Africa Long Acting Insulins Forecast by Region (2026-2031)
  10.5.1 Egypt Market Long Acting Insulins Forecast
  10.5.2 South Africa Market Long Acting Insulins Forecast
  10.5.3 Israel Market Long Acting Insulins Forecast
  10.5.4 Turkey Market Long Acting Insulins Forecast
10.6 Global Long Acting Insulins Forecast by Type (2026-2031)
10.7 Global Long Acting Insulins Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Long Acting Insulins Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novo Nordisk
  11.1.1 Novo Nordisk Company Information
  11.1.2 Novo Nordisk Long Acting Insulins Product Offered
  11.1.3 Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novo Nordisk Main Business Overview
  11.1.5 Novo Nordisk Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Long Acting Insulins Product Offered
  11.2.3 Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 Wockhardt UK
  11.3.1 Wockhardt UK Company Information
  11.3.2 Wockhardt UK Long Acting Insulins Product Offered
  11.3.3 Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Wockhardt UK Main Business Overview
  11.3.5 Wockhardt UK Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Long Acting Insulins Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Long Acting Insulins Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Insulin Glargine
Table 4. Major Players of Insulin Determir
Table 5. Major Players of Insulin Degludec
Table 6. Major Players of Long Acting Animal Insulin
Table 7. Long Acting Insulins Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Long Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Long Acting Insulins Market Size Market Share by Type (2020-2025)
Table 10. Long Acting Insulins Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Long Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Long Acting Insulins Market Size Market Share by Application (2020-2025)
Table 13. Global Long Acting Insulins Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Long Acting Insulins Revenue Market Share by Player (2020-2025)
Table 15. Long Acting Insulins Key Players Head office and Products Offered
Table 16. Long Acting Insulins Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Long Acting Insulins Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Long Acting Insulins Market Size Market Share by Region (2020-2025)
Table 21. Global Long Acting Insulins Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Long Acting Insulins Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Long Acting Insulins Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Long Acting Insulins Market Size Market Share by Country (2020-2025)
Table 25. Americas Long Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Long Acting Insulins Market Size Market Share by Type (2020-2025)
Table 27. Americas Long Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Long Acting Insulins Market Size Market Share by Application (2020-2025)
Table 29. APAC Long Acting Insulins Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Long Acting Insulins Market Size Market Share by Region (2020-2025)
Table 31. APAC Long Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Long Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Long Acting Insulins Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Long Acting Insulins Market Size Market Share by Country (2020-2025)
Table 35. Europe Long Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Long Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Long Acting Insulins Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Long Acting Insulins Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Long Acting Insulins Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Long Acting Insulins
Table 41. Key Market Challenges & Risks of Long Acting Insulins
Table 42. Key Industry Trends of Long Acting Insulins
Table 43. Global Long Acting Insulins Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Long Acting Insulins Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Long Acting Insulins Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Long Acting Insulins Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Novo Nordisk Details, Company Type, Long Acting Insulins Area Served and Its Competitors
Table 48. Novo Nordisk Long Acting Insulins Product Offered
Table 49. Novo Nordisk Long Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Novo Nordisk Main Business
Table 51. Novo Nordisk Latest Developments
Table 52. Sanofi Details, Company Type, Long Acting Insulins Area Served and Its Competitors
Table 53. Sanofi Long Acting Insulins Product Offered
Table 54. Sanofi Long Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. Wockhardt UK Details, Company Type, Long Acting Insulins Area Served and Its Competitors
Table 58. Wockhardt UK Long Acting Insulins Product Offered
Table 59. Wockhardt UK Long Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Wockhardt UK Main Business
Table 61. Wockhardt UK Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Long Acting Insulins Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long Acting Insulins Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Long Acting Insulins Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Long Acting Insulins Sales Market Share by Country/Region (2024)
Figure 8. Long Acting Insulins Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Long Acting Insulins Market Size Market Share by Type in 2024
Figure 10. Long Acting Insulins in Home Use
Figure 11. Global Long Acting Insulins Market: Home Use (2020-2025) & ($ millions)
Figure 12. Long Acting Insulins in Medical Institutions
Figure 13. Global Long Acting Insulins Market: Medical Institutions (2020-2025) & ($ millions)
Figure 14. Long Acting Insulins in Others
Figure 15. Global Long Acting Insulins Market: Others (2020-2025) & ($ millions)
Figure 16. Global Long Acting Insulins Market Size Market Share by Application in 2024
Figure 17. Global Long Acting Insulins Revenue Market Share by Player in 2024
Figure 18. Global Long Acting Insulins Market Size Market Share by Region (2020-2025)
Figure 19. Americas Long Acting Insulins Market Size 2020-2025 ($ millions)
Figure 20. APAC Long Acting Insulins Market Size 2020-2025 ($ millions)
Figure 21. Europe Long Acting Insulins Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Long Acting Insulins Market Size 2020-2025 ($ millions)
Figure 23. Americas Long Acting Insulins Value Market Share by Country in 2024
Figure 24. United States Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Long Acting Insulins Market Size Market Share by Region in 2024
Figure 29. APAC Long Acting Insulins Market Size Market Share by Type (2020-2025)
Figure 30. APAC Long Acting Insulins Market Size Market Share by Application (2020-2025)
Figure 31. China Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 35. India Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Long Acting Insulins Market Size Market Share by Country in 2024
Figure 38. Europe Long Acting Insulins Market Size Market Share by Type (2020-2025)
Figure 39. Europe Long Acting Insulins Market Size Market Share by Application (2020-2025)
Figure 40. Germany Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 41. France Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Long Acting Insulins Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Long Acting Insulins Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Long Acting Insulins Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Long Acting Insulins Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 54. APAC Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 55. Europe Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 57. United States Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 58. Canada Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 59. Mexico Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 60. Brazil Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 61. China Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 62. Japan Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 63. Korea Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 65. India Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 66. Australia Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 67. Germany Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 68. France Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 69. UK Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 70. Italy Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 71. Russia Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 72. Egypt Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 73. South Africa Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 74. Israel Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 75. Turkey Long Acting Insulins Market Size 2026-2031 ($ millions)
Figure 76. Global Long Acting Insulins Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Long Acting Insulins Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Long Acting Insulins Market Size 2026-2031 ($ millions)